AAAAAA
Results:
1-16
|
Results: 16
EVALUATION OF ENALAPRIL COMBINED WITH DILTIAZEM ER IN PATIENTS WITH STAGE-3-4 ESSENTIAL-HYPERTENSION
Authors:
GAVRAS H
CHRYSANT SG
NIEDERMAN AL
MARBURY TC
GOLDSTEIN R
CONRADI E
Citation: H. Gavras et al., EVALUATION OF ENALAPRIL COMBINED WITH DILTIAZEM ER IN PATIENTS WITH STAGE-3-4 ESSENTIAL-HYPERTENSION, Clinical and experimental hypertension, 20(1), 1998, pp. 41-52
Authors:
CUSHMAN WC
COHEN JD
JONES RP
MARBURY TC
RHOADES RB
SMITH LK
Citation: Wc. Cushman et al., COMPARISON OF THE FIXED COMBINATION OF ENALAPRIL DILTIAZEM ER AND THEIR MONOTHERAPIES IN STAGE-1 TO STAGE-3 ESSENTIAL-HYPERTENSION/, American journal of hypertension, 11(1), 1998, pp. 23-30
Authors:
MARBURY TC
HATORP V
DAMSBO P
MULLER PG
Citation: Tc. Marbury et al., REPAGLINIDE CAN BE GIVEN IN A FLEXIBLE PREPRANDIAL DOSING REGIMEN IN PATIENTS WITH TYPE-2 DIABETES, Diabetologia, 41, 1998, pp. 913-913
Authors:
MARBURY TC
STRANGE P
Citation: Tc. Marbury et P. Strange, MULTICENTER, RANDOMIZED COMPARISON OF THE THERAPEUTIC EFFECTS OF LONG-TERM USE OF REPAGLINIDE WITH GLYBURIDE IN TYPE-2 DIABETES, Diabetes, 47, 1998, pp. 292-292
Authors:
MARBURY TC
HATORP V
DAMSBO P
MULLER PG
Citation: Tc. Marbury et al., REPAGLINIDE CAN BE GIVEN IN A FLEXIBLE PREPRANDIAL DOSING REGIMEN IN PATIENTS WITH TYPE-2 DIABETES, Diabetes, 47, 1998, pp. 1373-1373
Authors:
MARBURY TC
HATORP V
Citation: Tc. Marbury et V. Hatorp, PHARMACOKINETICS OF REPAGLINIDE AFTER SINGLE AND MULTIPLE DOSES IN PATIENTS WITH RENAL IMPAIRMENT COMPARED WITH NORMAL HEALTHY-VOLUNTEERS, Diabetes, 47, 1998, pp. 1381-1381
Authors:
SIMONSON DC
KOURIDES IA
FEINGLOS M
SHAMOON H
FISCHETTE CT
ARONOFF S
BLONDE L
CEFALU W
CLEMENT S
GREENBERG C
LEVIN S
LUCAS CP
MACY C
MANNING J
MARBURY TC
MCADAMS MJ
MEZITIS NHE
MILLER S
OWENS D
SANDLER J
SCHWARTZ SL
SHAMOON H
SOSENKO J
Citation: Dc. Simonson et al., EFFICACY, SAFETY, AND DOSE-RESPONSE CHARACTERISTICS OF GLIPIZIDE GASTROINTESTINAL THERAPEUTIC SYSTEM ON GLYCEMIC CONTROL AND INSULIN-SECRETION IN NIDDM - RESULTS OF 2 MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL-TRIALS, Diabetes care, 20(4), 1997, pp. 597-606
Authors:
CHRYSANT SG
GAVRAS H
NIEDERMAN AL
MARBURY TC
GOLDSTEIN R
Citation: Sg. Chrysant et al., CLINICAL UTILITY OF LONG-TERM ENALAPRIL DILTIAZEM ER IN STAGE-3-4 ESSENTIAL-HYPERTENSION, Journal of clinical pharmacology, 37(9), 1997, pp. 810-815
Authors:
ALLGREN RL
MARBURY TC
RAHMAN SN
WEISBERG LS
FENVES AZ
LAFAYETTE RA
SWEET RM
GENTER FC
KURNIK BRC
CONGER JD
SAYEGH MH
Citation: Rl. Allgren et al., ANARITIDE IN ACUTE TUBULAR-NECROSIS, The New England journal of medicine, 336(12), 1997, pp. 828-834
Authors:
LAROCHELLE P
FLACK JM
MARBURY TC
SARELI P
KRIEGER EM
REEVES RA
Citation: P. Larochelle et al., EFFECTS AND TOLERABILITY AT IRBESARTAN VERSUS ENALAPRIL IN PATIENTS WITH SEVERE HYPERTENSION, The American journal of cardiology, 80(12), 1997, pp. 1613
Authors:
MARBURY TC
ANGELO JE
GULLEY RM
KROSNICK A
SUGIMOTO DH
ZELLNER SR
Citation: Tc. Marbury et al., A PLACEBO-CONTROLLED, DOSE-RESPONSE STUDY OF DEXFENFLURAMINE IN THE TREATMENT OF OBESE PATIENTS, Current therapeutic research, 57(9), 1996, pp. 663-674
Authors:
MARBURY TC
RAHMAN SN
SWEET RM
FENVES AZ
WEISBERG L
LAFAYETTE RA
GENTER FC
ALLGREN RL
Citation: Tc. Marbury et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTI CENTER CLINICAL-TRIAL OF ANARITIDE ATRIAL-NATRIURETIC-PEPTIDE (ANP) IN THE TREATMENT OF ATN, Journal of the American Society of Nephrology, 6(3), 1995, pp. 470-470
Authors:
RAHMAN SN
BUTT AR
DUBOSE TD
MARBURY TC
SWEET RN
WEISBERG L
FENVES AZ
Citation: Sn. Rahman et al., DIFFERENTIAL CLINICAL EFFECTS OF ANARITIDE ATRIAL-NATRIURETIC-PEPTIDE(ANP) IN OLIGURIC AND NON-OLIGURIC ATN, Journal of the American Society of Nephrology, 6(3), 1995, pp. 474-474
Authors:
TRONIER B
MARBURY TC
DAMSBO P
Citation: B. Tronier et al., A NEW ORAL HYPOGLYCEMIC AGENT, REPAGLINIDE MINIMIZES RISK OF HYPOGLYCEMIA IN WELL-CONTROLLED NIDDM PATIENTS, Diabetologia, 38, 1995, pp. 195-195
Authors:
TRONIER B
MARBURY TC
DAMSBO P
WINDFELD K
Citation: B. Tronier et al., A NEW ORAL HYPOGLYCEMIC AGENT, REPAGLINIDE MINIMIZES RISK OF HYPOGLYCEMIA IN WELL-CONTROLLED TYPE-2 DIABETIC-PATIENTS, Diabetes, 44, 1995, pp. 70-70
Authors:
CHRYSANT SG
ANGELO JE
CHINOY DA
GALICHIA JP
GLAZER N
HARRIS SI
JAIN AK
KAIHLANEN PM
KAPSNER CO
KERN JM
KORNBLIT MJ
MARBURY TC
MILLER E
MILLER WE
REEVES RL
RUDDY TD
SANDALL PG
SERFER HM
SUSSEX BA
THADANI U
WEIR MR
Citation: Sg. Chrysant et al., ANTIHYPERTENSIVE EFFECTIVENESS OF LOW-DOSE LISINOPRIL-HYDROCHLOROTHIAZIDE COMBINATION - A LARGE MULTICENTER STUDY, Archives of internal medicine, 154(7), 1994, pp. 737-743
Risultati:
1-16
|